Vol.

No.

April 27, 2018Apr 27, 2018

Free

DOWNLOAD THE PDF

Miami's Sylvester uses cool art to bridge disparities—and meet NCI's new requirement

Cover Story

Free

Miami's Sylvester uses cool art to bridge disparities—and meet NCI's new requirement

By Paul Goldberg

In New York City, Peter Tunney's billboard greets you as you enter the Midtown Tunnel: “Welcome to the CITY OF DREAMS” and ushers you out with a “You are now leaving the CITY OF DREAMS.”

Conversation with The Cancer Letter Free

Peter Tunney: How the largest art movement in history can help reduce cancer disparities

By Paul Goldberg

Clinical Free Trials & Tribulations

Learning to “talk less and smile more” while designing a COE strategy worthy of trust

By Erin N. Kobetz

In Brief

John Sampson to lead Duke's physician practice of over 1,500 members

Carl Schmidt joins WVU Cancer Institute

NCCN publishes translations of guidelines for patients

Melanoma Research Alliance announces $11.8 Million in 28 research grants

2018 Awards

Young Investigator Awards

Clinical Roundup

TESARO announces positive top-line results from Quadra trial of Zejula

Drugs & Targets

Mylotarg approved in EU for previously untreated, de novo, CD33-positive AML in combination with Chemotherapy

Nektar, Takeda to evaluate combining CD122-biased agonist and dual SYK and FLT-3 inhibitor

Pfizer gets Complete Response Letter for trastuzumab biosimilar

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues